Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 205,572,032
  • Shares Outstanding, K 3,100,634
  • Annual Sales, $ 45,811 M
  • Annual Income, $ 5,955 M
  • EBIT $ 9,201 M
  • EBITDA $ 14,588 M
  • 60-Month Beta 0.45
  • Price/Sales 4.51
  • Price/Cash Flow 12.35
  • Price/Book 5.06

Options Overview Details

View History
  • Implied Volatility 20.12% ( -0.88%)
  • Historical Volatility 21.96%
  • IV Percentile 25%
  • IV Rank 22.90%
  • IV High 34.77% on 10/31/24
  • IV Low 15.77% on 05/28/24
  • Put/Call Vol Ratio 1.51
  • Today's Volume 4,485
  • Volume Avg (30-Day) 9,497
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 155,236
  • Open Int (30-Day) 166,510

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.06
  • Number of Estimates 6
  • High Estimate 1.21
  • Low Estimate 0.97
  • Prior Year 0.73
  • Growth Rate Est. (year over year) +45.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.75 +4.34%
on 12/20/24
69.00 -3.59%
on 12/09/24
+0.16 (+0.24%)
since 11/26/24
3-Month
62.75 +6.01%
on 11/18/24
79.76 -16.60%
on 10/02/24
-11.66 (-14.91%)
since 09/26/24
52-Week
60.47 +10.00%
on 02/12/24
87.68 -24.13%
on 08/30/24
+0.02 (+0.03%)
since 12/26/23

Most Recent Stories

More News
AZN, Daiichi Withdraw EU Filing for Dato-DXd in Nonsquamous NSCLC

AstraZeneca AZN and its Japanese partner Daiichi Sankyo announced that they have voluntarily withdrawn the marketing authorization application (MAA) for their antibody-drug conjugate (ADC), datopotamab...

AZN : 66.52 (+0.33%)
MRK : 99.87 (+0.42%)
PFE : 26.56 (-0.67%)
Pharma Stock Roundup: NVO's Obesity Study Failure, FDA Nod to PFE, LLY

This week, Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly’s LLY Zepbound for treating moderate-to-severe obstructive sleep...

AZN : 66.52 (+0.33%)
NVO : 87.65 (+0.32%)
LLY : 794.14 (-0.19%)
PFE : 26.56 (-0.67%)
SNY : 48.43 (+0.29%)
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NYSE:ABBV),(NASDAQ:CRDF) EQNX::TICKER_END

ONCY : 1.0009 (+3.19%)
AZN : 66.52 (+0.33%)
ABBV : 179.20 (-0.44%)
ONC.TO : 1.41 (+9.30%)
GSK : 34.12 (+0.26%)
CRDF : 4.34 (+10.71%)
Why IonQ Is the Best Quantum Computing Stock to Buy Right Now

Quantum computing represents the next frontier in computational power. Once developed, these systems could solve complex problems in drug development, financial modeling, and artificial intelligence (AI)...

MSFT : 438.11 (-0.28%)
GOOGL : 195.60 (-0.26%)
GOOG : 197.10 (-0.24%)
LMT : 489.98 (+0.38%)
ANSS : 340.16 (-0.78%)
AZN : 66.52 (+0.33%)
IONQ : 48.24 (+8.21%)
QTUM : 83.99 (+1.63%)
AMZN : 227.05 (-0.87%)
Is AstraZeneca Stock a Buy?

U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company's president in the country -- as...

AZN : 66.52 (+0.33%)
1 Quantum Computing Stock to Buy Hand Over Fist

As quantum computing is poised to thrive with AI breakthroughs and government backing, this stock’s immense potential makes it a must-have for investors now.

ANSS : 340.16 (-0.78%)
AZN : 66.52 (+0.33%)
IONQ : 48.24 (+8.21%)
Merck's BLA for RSV Antibody Clesrovimab Gets FDA Acceptance

Merck MRK announced that the FDA has accepted the biologics license application (BLA) for its investigational prophylactic long-acting monoclonal antibody, clesrovimab (MK-1654), designed to protect infants...

AZN : 66.52 (+0.33%)
MRK : 99.87 (+0.42%)
PFE : 26.56 (-0.67%)
SNY : 48.43 (+0.29%)
3 Unstoppable Stocks to Buy Right Now

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business fundamentals. Three Motley Fool contributors believe they've found stocks in the latter...

AZN : 66.52 (+0.33%)
VRTX : 410.65 (+0.61%)
LLY : 794.14 (-0.19%)
Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study

Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered investigational drug imlunestrant significantly reduced the risk of disease progression...

AZN : 66.52 (+0.33%)
NVO : 87.65 (+0.32%)
LLY : 794.14 (-0.19%)
3 Penny Stocks With 10% to 210% Upside Potential

Investors should consider these three penny stocks for their solid upside potential, even after this year's rally.

CGEN : 1.6300 (+1.87%)
MAPS : 1.4900 (-6.29%)
AZN : 66.52 (+0.33%)
$SPX : 6,037.59 (-0.04%)
GCG25 : 2,648.0 (-0.22%)
NGD : 2.52 (unch)
GILD : 94.41 (+0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 67.65
2nd Resistance Point 67.16
1st Resistance Point 66.84
Last Price 66.52
1st Support Level 66.03
2nd Support Level 65.54
3rd Support Level 65.22

See More

52-Week High 87.68
Fibonacci 61.8% 77.28
Fibonacci 50% 74.07
Fibonacci 38.2% 70.86
Last Price 66.52
52-Week Low 60.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar